FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

12578001: Erythromycin ethylsuccinate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
21620019 Erythromycin ethylsuccinate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
729651015 Erythromycin ethylsuccinate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2691868015 Erythromycin ethyl succinate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
21620019 Erythromycin ethylsuccinate en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
21620019 Erythromycin ethylsuccinate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
729651015 Erythromycin ethylsuccinate (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
729651015 Erythromycin ethylsuccinate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2691868015 Erythromycin ethyl succinate en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2691868015 Erythromycin ethyl succinate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
20281000188119 érythromycine éthylsuccinate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
809461000172111 éthylsuccinate d'érythromycine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
20281000188119 érythromycine éthylsuccinate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
809461000172111 éthylsuccinate d'érythromycine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Erythromycin ethylsuccinate (substance) Is a Product containing erythromycin (medicinal product) false Inferred relationship Existential restriction modifier (core metadata concept)
Erythromycin ethylsuccinate (substance) Is a Erythromycin (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Erythromycin ethylsuccinate (substance) Is a Substance with macrolide structure and antibacterial mechanism of action (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Erythromycin ethylsuccinate (substance) Is modification of (attribute) Erythromycin (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Erythromycin ethylsuccinate (substance) Has disposition Antibacterial (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Erythromycin ethyl succinate 200 mg chewable tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythromycin ethylsuccinate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Erythromycin ethylsuccinate 100 mg/2.5mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythromycin ethylsuccinate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely erythromycin ethylsuccinate 400 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythromycin ethylsuccinate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Erythromycin ethylsuccinate 400mg/5mL powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythromycin ethylsuccinate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Erythromycin ethylsuccinate 200mg/5mL suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythromycin ethylsuccinate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Erythromycin ethylsuccinate 100mg/2.5mL suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythromycin ethylsuccinate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Erythromycin ethylsuccinate 400mg/5mL suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythromycin ethylsuccinate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Erythromycin ethylsuccinate + sulfisoxazole acetyl ns/ns suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythromycin ethylsuccinate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing erythromycin ethylsuccinate and sulfafurazole acetyl The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythromycin ethylsuccinate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing erythromycin ethylsuccinate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythromycin ethylsuccinate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely erythromycin ethylsuccinate 400 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythromycin ethylsuccinate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely erythromycin ethylsuccinate 400 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Erythromycin ethylsuccinate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely erythromycin ethylsuccinate 400 milligram/1 each conventional release oral tablet Has precise active ingredient False Erythromycin ethylsuccinate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 100 milligram/1 milliliter conventional release oral suspension (clinical drug) Has precise active ingredient True Erythromycin ethylsuccinate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Erythromycin (as erythromycin ethyl succinate) 25 mg/mL oral suspension Has precise active ingredient True Erythromycin ethylsuccinate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 50 milligram/1 milliliter conventional release oral suspension (clinical drug) Has precise active ingredient True Erythromycin ethylsuccinate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Erythromycin ethyl succinate 200 mg chewable tablet Has precise active ingredient True Erythromycin ethylsuccinate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Erythromycin ethyl succinate 200 mg chewable tablet Has basis of strength substance (attribute) True Erythromycin ethylsuccinate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug) Has precise active ingredient True Erythromycin ethylsuccinate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 80 milligram/1 milliliter conventional release oral suspension (clinical drug) Has precise active ingredient True Erythromycin ethylsuccinate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Erythromycin (as erythromycin ethyl succinate) 400 mg oral tablet Has precise active ingredient True Erythromycin ethylsuccinate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start